EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction






Resuscitation 78(3): 258-264

Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction

Animal studies have demonstrated evidence of an anti-arrhythmic effect of marine n-3 fatty acids (FAs). In humans the same mechanism may explain the observed reduction in sudden cardiac death (SCD) associated with intake of fish. Whether high levels of n-3 FAs could protect against ventricular fibrillation (VF) during the acute ischaemic phase of a myocardial infarction (MI) is, however, not known. We measured red blood cell content of eicosapentaenoic acid (EPA)+docosahexaenoic acid (DHA) expressed as a percentage of total FAs (the omega-3 index) at admission in 460 patients hospitalised with an acute coronary syndrome. Out of 265 patients suffering their first MI, 10 (cases) experienced an episode of VF during the initial 6h of symptom onset. The omega-3 index of these patients was compared to that of 185 first-MI patients (controls) free of VF for at least 30 days post-admission. The median value of the omega-3 index in the VF cases was 4.88% as compared to 6.08% in the controls (p=0.013). After adjustment for age, sex, ejection fraction, high-sensitivity C-reactive protein, use of beta-blocker, differences of infarct characteristics and previous angina pectoris, a 1% increase of the omega-3 index was associated with a 48% reduction in risk of VF (odds ratio (OR) 0.52, 95% confidence interval (CI) 0.28-0.96; p=0.037). Our study supports an anti-arrhythmic effect of n-3 FAs through their incorporation into myocardial cell membranes, reducing the risk of VF during ischaemia.


Accession: 054185067

PMID: 18556107

DOI: 10.1016/j.resuscitation.2008.04.007



Related references

Dłuzniewski, M.; Kułakowski, P.; Senatorski, M.; Ceremuzyński, L., 1988: Late potentials in the acute phase of myocardial infarction indicate the risk of early ventricular fibrillation. Late potentials occurring at the end of or after the QRS complex were recorded from the body surface by means of a high-gain ECG and the signal-averaging technique in 75 patients, within 24 h from the onset of symptoms of acute myocardial infarcti...

Rashba, E.J.; Zareba, W.; Moss, A.J., 1996: Dispersion of repolarization is associated with ventricular fibrillation, but not ventricular tachycardia, during the acute phase of myocardial infarction. Circulation 94(8 SUPPL ): I625

Depelchin P.; Sobolski J., 1984: Prophylaxis of ventricular fibrillation in the acute phase of myocardial infarction. The concept that primary ventricular fibrillation, the leading cause of death in acute myocardial infarction, is usually preceded by warning arrhythmias, has been seriously questioned in recent years. The usefulness of prophylactic antiarrhythymic...

Bertini G.; Giglioli C.; Margheri M.; Conti A.; Fattirolli F.; Giuntini F.; Mangialavori G.; Paterni M.; Daraio A., 1985: Ventricular fibrillation in the early phase of acute myocardial infarction. Giornale Italiano di Cardiologia 15(2): 169-176

Bernard, R.; Vainsel, H.; Dereume, G.; de Hemptinne, J.; Smets, P.; Englert, M., 1978: Primary ventricular fibrillation during the acute phase of myocardial infarction. Annales de Cardiologie et D'angeiologie 27(6): 463-465

Rashba, E.J.; Zareba, W.; Moss, A.J., 1996: QT dispersion is associated with ventricular fibrillation in the acute phase of myocardial infarction. European Heart Journal 17(ABSTR SUPPL ): 275

Piccini, J.P.; Hranitzky, P.M.; Kilaru, R.; Rouleau, J-Lucien.; White, H.D.; Aylward, P.E.; Van de Werf, F.; Solomon, S.D.; Califf, R.M.; Velazquez, E.J., 2008: Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Sustained ventricular arrhythmias and heart failure are well-recognized complications after acute myocardial infarction (AMI) and have been associated with worse outcomes and increased mortality. The use of and outcomes associated with acute beta-...

Berger, P.B.; Ruocco, N.A.; Ryan, T.J.; Frederick, M.M.; Podrid, P.J., 1993: Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. Objectives. The purpose of this study was to determine the incidence of ventricular tachycardia and fibrillation without hypotension or heart failure after treatment with recombinant tissue-type plasminogen activator (rt-PA), anatomic correlates o...

Touche, M.; Touche, S.; Jouvet, M.; Trouve, P., 1973: Ventricular fibrillation at the acute phase of myocardial infarction: prognosis after resuscitation. Archives des Maladies du Coeur et des Vaisseaux 66(11): 1435-1441

Derejko, Pł.; Witkowski, A.; Walczak, F.; Szumowski, L.; Szufladowicz, E.; Bodalski, R.; Urbanek, P.; Nyznyk, M.; Szajewski, T., 2005: Ventricular fibrillation in acute phase of myocardial infarction in a patient with WPW syndrome. Kardiologia Polska 62(4): 409-415